stars 1 stars 2 stars 3

Simris Group is a biotech company, engaged in research, development and production of bioactive substances from cyanobacteria and microalgae for pharmaceutical applications. At Simris, we are pioneering the next generation of ADC payloads to revolutionise cancer treatment. Our platform is built on the world’s largest cyanobacterial strain library and over two decades of deep scientific expertise. Through our proprietary discovery and bioconjugation technologies, we are developing novel, IP-protected payloads with the potential to dramatically improve both the efficacy and safety of ADC therapeutics. Our headquarters are located in Hammenhög, Sweden. Simris Group AB is a public company and our stock is traded on the Nasdaq First North stock exchange (FNSE:SIMRIS B). http://www.simrisgroup.com http://www.simrisbiologics.com

Simris Alg Questions

Frank Puccio is the Director of Simris Alg.

3 people are employed at Simris Alg.

Top Simris Alg Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users